Stephen Gabriel Andrews,Steven D Forsythe,James P Madigan et al.
Stephen Gabriel Andrews et al.
Small intestinal neuroendocrine tumors, siNETs, are a group of rare cancers that arise from neuroendocrine cells in the lining of the jejunum and ileum, which are either classified as tumors, siNETs, or small intestinal neuroendocrine carci...
Predictors of hypocalcaemia and hypoparathyroidism in patients undergoing thyroidectomy for benign and malignant pathologies [0.03%]
良性及恶性甲状腺手术患者的低钙血症和甲状旁腺功能减退的预测因素分析
Jino Johns Lalitha,Natarajan Ramalingam,Remya Rajan et al.
Jino Johns Lalitha et al.
Objective: To analyse the risk factors of hypoparathyroidism and hypocalcaemia after total thyroidectomy. Methods: Clinical data of pat...
Anassuya Ramachandran,Polona Le Quesne Stabej,Veronica Boyle et al.
Anassuya Ramachandran et al.
Although the gene MEN1 has a long-standing association with cancer, its mechanisms of action remain incompletely understood, acting both as a tumour suppressor in neuroendocrine tumours and as an oncogene in leukaemia. The best-characterise...
Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms [0.03%]
异位库欣综合征伴发神经内分泌肿瘤转移的肽受体放射性核素治疗
Emma Boehm,Terry Hung,Tim Akhurst et al.
Emma Boehm et al.
Background: Metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNEN) can cause ectopic Cushing's syndrome (ECS). ECS is highly morbid and medical therapy is complex and can be ineffective. Patients unsuitable f...
Time toxicity of lutetium 177 in gastroenteropancreatic neuroendocrine tumours [0.03%]
镥-177的时效毒理学在胃肠胰神经内分泌肿瘤中的研究
Marcos Daniel Bortz,Andres Rodriguez,Maria Romina Luca et al.
Marcos Daniel Bortz et al.
Objectives: We aim to investigate the time toxicity of patients with gastroenteropancreatic neuroendocrine tumours treated with Lutetium-177 Dotatate in a single institution. ...
Caitlin B Mauer Hall,Elise M Watson,Tanushree Prasad et al.
Caitlin B Mauer Hall et al.
Background: Approximately 30-40% of paragangliomas (PGLs) and pheochromocytomas (PCCs) harbor an underlying hereditary cause. Early identification of at-risk individuals is imperative given the early onset, aggressiveness...
Less frequent radiological exams to avoid futile response assessments from 177-LuDOTATE therapy for patients with advanced neuroendocrine tumors [0.03%]
减少放射学检查以避免对177-LuDOTATE治疗晚期神经内分泌肿瘤的无效反应评估
Carolina C Marques,Angelo B Brito,Eduardo N Lima et al.
Carolina C Marques et al.
Background: 177-LuDOTATE is an effective but expensive treatment for neuroendocrine tumors (NETs). Reducing treatment-related costs, such as the number of images, could improve access to 177-LuDOTATE. We evaluated early r...
Elisa Lamback,Renan Lyra Miranda,Leila Chimelli et al.
Elisa Lamback et al.
Pituitary gigantism is a rare pediatric disorder caused by excess growth hormone (GH) secretion. In almost 50% of cases, a genetic cause can be identified, with pathogenic variants in the aryl hydrocarbon receptor-interacting protein (AIP) ...
Differential utilization of thyroid lobectomy after the 2015 American Thyroid Association guideline update [0.03%]
2015年美国甲状腺协会指南更新后甲状腺叶切除术的应用差异性分析
Patricia Gina Lu,Zhi Ven Fong,Patrick T Hangge et al.
Patricia Gina Lu et al.
Background: The 2015 American Thyroid Association (ATA) guidelines added thyroid lobectomy (TL) as the appropriate treatment for low-risk differentiated thyroid cancer (DTC). We aimed to investigate the population-level f...
Histopathological analysis potential for unveiling hormone signaling in endocrine-related tumors [0.03%]
激素信号在内分泌相关肿瘤中的组织病理分析潜力
Yasuhiro Miki,Erina Iwabuchi,Chihiro Inoue et al.
Yasuhiro Miki et al.
Elucidating the mechanisms of action of steroid hormones will contribute to the development of therapeutic strategies for hormone-dependent tumors. Recent advances in genetic engineering have revealed the complex and diverse mechanisms of s...